AGN News and Press, Allergan plc From 04/20/20

AbbVie ( ABBV ), a major pharmaceutical company focused primarily in the United States, has provided strong dividend growth since its inception. Not only is AbbVie’s dividend at an attractive starting yield of over 5.5%, but the company has also managed an impressive 20% five-year divid...

AbbVie Inc.: Investment Thesis Source: AbbVie.com AbbVie's potential returns based on share prices returning to Feb. 21, 2020, levels: Table 1 Table 1.1 Table 1.2 Table 1.1 shows the three biotechs, AbbVie ( ABBV ), Amgen ( AMGN ), and Gilead ( GILD ). AbbVie has the high...

Recent market volatility has unfairly whipsawed many stocks that are usually considered steady eddies, and the effects have been even stronger for specific sectors and speculative stocks. That said, some stocks were wildly overvalued when the market was hitting new highs not so long ago, and wer...

Developed in the 1970’s, Ifenprodil, a drug originally developed by Sanofi, has been sitting quietly on the approved drug list in Japan for over 45 years. Treating neurological conditions like vertigo and dizziness, it’s real potential hidden until recently, when a Canadian comp...

New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Breast Implants Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer updates and information related to fut...

New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Dermal Facial Fillers Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer updates and information related t...

New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Dermal Infilling Materials Market in Global Industry: 2020 Research and New Innovations in Machines Sector. The prime objective of the report is to offer updates and information related to future opportu...

I’m writing this after market close and the S&P 500 ( SPY ) and the Dow (DJI) are up 7%-8% again. It is quite the bear rally from the lows in March. I’m watching Twitter, talking to other investors, listening to CNBC, lots of investment podcasts, and of course, reading the fi...

Shares of AbbVie (NYSE: ABBV) , a blue-chip biopharma, fell by a staggering 11.1% in March, according to data from  S&P Global Market Intelligence . This large-cap biopharma thus lost approximately $20 billion in market capitalization last month. On the bright side, AbbVie's st...

Article Thesis During times of crisis, not all companies fare the same, and this also holds true for their stocks. Dividend Aristocrats and Dividend Kings, which have raised their dividends annually for decades, have a history of performing better than broad markets during bad times. We wi...